Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Jul 14, 2022

BUY
$2.35 - $3.47 $235 - $347
100 New
100 $0
Q4 2021

Jan 21, 2022

SELL
$2.92 - $5.74 $292 - $574
-100 Closed
0 $0
Q2 2017

Aug 10, 2018

BUY
N/A
100 New
100 $0
Q1 2017

Aug 10, 2018

SELL
N/A
-100 Closed
0 $0
Q4 2016

Aug 10, 2018

BUY
N/A
100
100 $0

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.